Results 121 to 130 of about 6,163 (183)

ACE inhibitor-induced isolated intestinal angioedema mimicking functional bowel disorder: a case report. [PDF]

BMC Gastroenterol
Prasad S, Nagda J, Ahuja A, Agrawal S, Parmar V.   +4 more
europepmc   +1 more source

Successful Management of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema With Tranexamic Acid: A Case Report. [PDF]

Cureus
Ibrahem M.
europepmc   +1 more source

Case Report: Hereditary Angioedema Accompanied by Chronic Spontaneous Urticaria. [PDF]

Clin Cosmet Investig Dermatol
Wang H, Shen Y.
europepmc   +1 more source

Control of B2 bradykinin receptor gene expression

openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Activation of B2 bradykinin receptors by neurotensin

Cellular Signalling, 2003
Many previous reports suggested that relatively high concentrations of neurotensin were required to exert its effects on neurotransmitter secretion. The neurotensin binding sites, which recognize high concentrations of neurotensin, were characterized in rat pheochromocytoma (PC12) cells. When PC12 cells were treated with neurotensin, [3H]norepinephrine
Park, TJ, Kim, KT
openaire   +3 more sources

The Bradykinin B2-Receptor in Human Decidua

Seminars in Thrombosis and Hemostasis, 1999
Bacterial infection of the amniotic cavity is one of the most frequent causes of preterm delivery. Bacterial products activate a network of autocrine and paracrine mediators in fetal membranes and decidua, with prostaglandins finally inducing contractions of the myometrium. Bradykinin and its B2-receptor (B2R) seem to be part of this network.
P, Buchinger, J, Rehbock
openaire   +2 more sources

Bradykinin receptor types and B2 subtypes

Life Sciences, 1994
Bradykinin, desArg9BK, some agonist analogues and several antagonists have been tested in isolated organs in order to identify bradykinin B2 receptor subtypes. The initial pharmacological characterization was made in the rabbit jugular vein and the guinea pig ileum, two widely used B2 preparations which have shown marked differences in their ...
D, Regoli, F, Gobeil, Q T, Nguyen, D, Jukic, P R, Seoane, J M, Salvino, D G, Sawutz   +6 more
openaire   +2 more sources

Intracellular and nuclear bradykinin B2 receptors

European Journal of Pharmacology, 2014
Bradykinin is a vasoactive peptide that participates in numerous inflammatory processes, vasodilation, and cell growth/survival; it mainly acts through two receptor subtypes, bradykinin B1 and bradykinin B2 receptors, which are G protein-coupled receptor (GPCR) family members.
Masaoki Takano, Shogo Matsuyama
openaire   +2 more sources

New selective bradykinin receptor antagonists and bradykinin B2 receptor characterization

Trends in Pharmacological Sciences, 1990
Substantial progress has been made recently in the field of kinin pharmacology with the identification of sensitive bioassay organs and the discovery of bradykinin B2 receptor antagonists. Data obtained with such compounds in various laboratories support the hypothesis that kinins act on multiple (at least two) receptor types.
D, Regoli, N E, Rhaleb, S, Dion, G, Drapeau   +3 more
openaire   +2 more sources